97 related articles for article (PubMed ID: 31762409)
1. RTD-1 therapeutically normalizes synovial gene signatures in rat autoimmune arthritis and suppresses proinflammatory mediators in RA synovial fibroblasts.
Tongaonkar P; Punj V; Subramanian A; Tran DQ; Trinh KK; Schaal JB; Laragione T; Ouellette AJ; Gulko PS; Selsted ME
Physiol Genomics; 2019 Dec; 51(12):657-667. PubMed ID: 31762409
[TBL] [Abstract][Full Text] [Related]
2. A Review of Proposed Mechanisms in Rheumatoid Arthritis and Therapeutic Strategies for the Disease.
Mohite R; Doshi G
Endocr Metab Immune Disord Drug Targets; 2024; 24(3):291-301. PubMed ID: 37861027
[TBL] [Abstract][Full Text] [Related]
3. Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis.
Falconer J; Murphy AN; Young SP; Clark AR; Tiziani S; Guma M; Buckley CD
Arthritis Rheumatol; 2018 Jul; 70(7):984-999. PubMed ID: 29579371
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibitor targets fibroblast metabolism in RA.
McHugh J
Nat Rev Rheumatol; 2023 Dec; 19(12):760. PubMed ID: 37903918
[No Abstract] [Full Text] [Related]
5. Antioxidant Carbon Nanoparticles Inhibit Fibroblast-Like Synoviocyte Invasiveness and Reduce Disease Severity in a Rat Model of Rheumatoid Arthritis.
Tanner MR; Huq R; Sikkema WKA; Nilewski LG; Yosef N; Schmitt C; Flores-Suarez CP; Raugh A; Laragione T; Gulko PS; Tour JM; Beeton C
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33081234
[TBL] [Abstract][Full Text] [Related]
6. Pyridostigmine ameliorates pristane-induced arthritis symptoms in Dark Agouti rats.
Zeng M; Issotina Zibrila A; Li X; Liu X; Wang X; Zeng Z; Wang Z; He Y; Meng L; Liu J
Scand J Rheumatol; 2023 Nov; 52(6):627-636. PubMed ID: 37339380
[TBL] [Abstract][Full Text] [Related]
7. Targeting MyD88 Downregulates Inflammatory Mediators and Pathogenic Processes in PBMC From DMARDs-Naïve Rheumatoid Arthritis Patients.
Ramirez-Perez S; Oregon-Romero E; Reyes-Perez IV; Bhattaram P
Front Pharmacol; 2021; 12():800220. PubMed ID: 35002734
[TBL] [Abstract][Full Text] [Related]
8. Dynamic spectrum of ectopic lymphoid B cell activation and hypermutation in the RA synovium characterized by NR4A nuclear receptor expression.
Meednu N; Rangel-Moreno J; Zhang F; Escalera-Rivera K; Corsiero E; Prediletto E; DiCarlo E; Goodman S; Donlin LT; Raychauduri S; Bombardieri M; Pitzalis C; Orange DE; ; McDavid A; Anolik JH
Cell Rep; 2022 May; 39(5):110766. PubMed ID: 35508128
[TBL] [Abstract][Full Text] [Related]
9. New Druggable Targets for Rheumatoid Arthritis Based on Insights From Synovial Biology.
Sandhu G; Thelma BK
Front Immunol; 2022; 13():834247. PubMed ID: 35265082
[TBL] [Abstract][Full Text] [Related]
10. Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysis.
Micheroli R; Elhai M; Edalat S; Frank-Bertoncelj M; Bürki K; Ciurea A; MacDonald L; Kurowska-Stolarska M; Lewis MJ; Goldmann K; Cubuk C; Kuret T; Distler O; Pitzalis C; Ospelt C
RMD Open; 2022 Jan; 8(1):. PubMed ID: 34987094
[TBL] [Abstract][Full Text] [Related]
11. Identification of arthritis-related gene clusters by microarray analysis of two independent mouse models for rheumatoid arthritis.
Fujikado N; Saijo S; Iwakura Y
Arthritis Res Ther; 2006; 8(4):R100. PubMed ID: 16805906
[TBL] [Abstract][Full Text] [Related]
12. Cell-Specific Gene Networks and Drivers in Rheumatoid Arthritis Synovial Tissues.
Pelissier A; Laragione T; Gulko PS; Rodríguez Martínez M
bioRxiv; 2024 Jan; ():. PubMed ID: 38234732
[TBL] [Abstract][Full Text] [Related]
13. Latent Factor Modeling of scRNA-Seq Data Uncovers Dysregulated Pathways in Autoimmune Disease Patients.
Palla G; Ferrero E
iScience; 2020 Sep; 23(9):101451. PubMed ID: 32853994
[TBL] [Abstract][Full Text] [Related]
14. Improving Transcriptome Fidelity Following Synovial Tissue Disaggregation.
Boyle DL; Prideaux EB; Hillman J; Wang W; Firestein GS
Front Med (Lausanne); 2022; 9():919748. PubMed ID: 36035425
[TBL] [Abstract][Full Text] [Related]
15. An ADAM10 Exosite Inhibitor Is Efficacious in an In Vivo Collagen-Induced Arthritis Model.
Diez J; Selsted ME; Bannister TD; Minond D
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256920
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-146a Expression and Regulation of Endotoxin Tolerance by Rhesus Theta-Defensin-1.
Tongaonkar P; Trinh KK; Ouellette AJ; Selsted ME
Mediators Inflamm; 2023; 2023():8387330. PubMed ID: 37101596
[TBL] [Abstract][Full Text] [Related]
17. Targeting protein-protein interaction for immunomodulation: A sunflower trypsin inhibitor analog peptidomimetic suppresses RA progression in CIA model.
Dahal A; Parajuli P; Singh SS; Shrestha L; Sonju JJ; Shrestha P; Chatzistamou I; Jois S
J Pharmacol Sci; 2022 Jul; 149(3):124-138. PubMed ID: 35641025
[TBL] [Abstract][Full Text] [Related]
18. Theta-Defensins to Counter COVID-19 as Furin Inhibitors:
Negahdaripour M; Rahbar MR; Mosalanejad Z; Gholami A
Comput Math Methods Med; 2022; 2022():9735626. PubMed ID: 35154362
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Pharmacokinetics and Safety of Intravenous RTD-1.
Park AYJ; Tran DQ; Schaal JB; Wang M; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0212521. PubMed ID: 35041507
[TBL] [Abstract][Full Text] [Related]
20. A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections.
Schaal JB; Eriguchi Y; Tran DQ; Tran PA; Hawes C; Cabebe AE; Pike K; Trinh K; Ouellette AJ; Selsted ME
Sci Rep; 2021 Dec; 11(1):23447. PubMed ID: 34873199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
